Patients with relatively higher XAF1 expression had a markedly lower long-term survival suggesting that XAF1 might not actually play in tumor suppressive or an apoptosis promoting role in GBM as is the case in other cancers. The gene discussed is XAF1; the disease is glioblastoma.